Trifluoroacetic acid in 2,2,2-trifluoroethanol facilitates S(N)Ar reactions of heterocycles with arylamines.
Small-molecule drug discovery requires reliable synthetic methods for attaching amino compounds to heterocyclic scaffolds. Trifluoroacetic acid-2,2,2-trifluoroethanol (TFA-TFE) is as an effective combination for achieving SN Ar reactions between anilines and heterocycles (e.g., purines and pyrimidines) substituted with a leaving group (fluoro-, chloro-, bromo- or alkylsulfonyl). This method provides a variety of compounds containing a "kinase-privileged fragment" associated with potent inhibition of kinases. TFE is an advantageous solvent because of its low nucleophilicity, ease of removal and ability to solubilise polar substrates. Furthermore, TFE may assist the breakdown of the Meisenheimer-Jackson intermediate by solvating the leaving group. TFA is a necessary and effective acidic catalyst, which activates the heterocycle by N-protonation without deactivating the aniline by conversion into an anilinium species. The TFA-TFE methodology is compatible with a variety of functional groups and complements organometallic alternatives, which are often disadvantageous because of the expense of reagents, the frequent need to explore diverse sets of reaction conditions, and problems with product purification. In contrast, product isolation from TFA-TFE reactions is straightforward: evaporation of the reaction mixture, basification and chromatography affords analytically pure material. A total of 45 examples are described with seven discrete heterocyclic scaffolds and 2-, 3- and 4-substituted anilines giving product yields that are normally in the range 50-90 %. Reactions can be performed with either conventional heating or microwave irradiation, with the latter often giving improved yields.
Newcastle Cancer Centre, Northern Institute for Cancer Research, Bedson Building, Newcastle University, Newcastle Upon Tyne, NE1 7RU (UK).
Benoit
B
Carbain
Christopher R
CR
Coxon
Honorine
H
Lebraud
Kristopher J
KJ
Elliott
Christopher J
CJ
Matheson
Elisa
E
Meschini
Amy R
AR
Roberts
David M
DM
Turner
Christopher
C
Wong
Celine
C
Cano
Roger J
RJ
Griffin
Ian R
IR
Hardcastle
Bernard T
BT
Golding
D000588:Amines / Q000737:chemistry*; D000814:Aniline Compounds / Q000737:chemistry*; D002384:Catalysis; D006571:Heterocyclic Compounds / Q000737:chemistry*; D008872:Microwaves; D015394:Molecular Structure; D011687:Purines / Q000737:chemistry*; D011743:Pyrimidines / Q000737:chemistry*; D014269:Trifluoroacetic Acid / Q000737:chemistry*; D014270:Trifluoroethanol / Q000737:chemistry*
D000588:Amines; D000814:Aniline Compounds; D006571:Heterocyclic Compounds; D011687:Purines; D011743:Pyrimidines; D014270:Trifluoroethanol; D014269:Trifluoroacetic Acid; C023650:aniline; C030985:purine
SNAr; catalysis; heterocyclic drugs; synthetic methods; trifluoroethanol